-
-
-
-
-
-
-
Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymp
-
-
-
-
-
-
-
Mizuho Upgrades Atara Biotherapeutics (ATRA) to Outperform
-
-
-
-
-
15,912 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


